Epidemiology

Cost-Effectiveness Study of Criteria for Screening Cerebrospinal Fluid To Determine the Need for Herpes Simplex Virus PCR Testing

Ronald G. Hauser, Sheldon M. Campbell, Cynthia A. Brandt, Shiyi Wang
Angela M. Caliendo, Editor
DOI: 10.1128/JCM.00119-17

Article Information

DOI 
https://doi.org/10.1128/JCM.00119-17
PubMed 
28298450
Published By 
American Society for Microbiology Journals
History 
  • Received January 19, 2017
  • Returned for modification February 8, 2017
  • Accepted March 2, 2017
  • Published online April 25, 2017.
Copyright & Usage 
Copyright © 2017 American Society for Microbiology. All Rights Reserved .
Editors and / or Reviewers 
  • Angela M. Caliendo, Editor, Rhode Island Hospital

Article Versions

Author Information

  1. Ronald G. Hausera,b,
  2. Sheldon M. Campbella,b,
  3. Cynthia A. Brandtb and
  4. Shiyi Wangc
  1. aYale University School of Medicine, New Haven, Connecticut, USA
  2. bVeterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA
  3. cYale University School of Public Health, Department of Chronic Disease Epidemiology, New Haven, Connecticut, USA
  • Address correspondence to Ronald G. Hauser, ronald.hauser{at}yale.edu.

  • Citation Hauser RG, Campbell SM, Brandt CA, Wang S. 2017. Cost-effectiveness study of criteria for screening cerebrospinal fluid to determine the need for herpes simplex virus PCR Testing. J Clin Microbiol 55:1566–1575. https://doi.org/10.1128/JCM.00119-17 .

View Abstract

Article usage

Article usage: March 2017 to January 2021

Rendering graph...
AbstractFullPdf
Mar 2017259028
Apr 2017980546
May 201710051437
Jun 20172871127
Jul 201710069
Aug 20176869
Sep 201765313
Oct 2017531126
Nov 2017741328
Dec 2017401023
Jan 2018491919
Feb 2018441112
Mar 2018633619
Apr 2018421718
May 201821918
Jun 2018121320
Jul 2018392520
Aug 2018281619
Sep 201811419
Oct 201882021
Nov 201857217
Dec 201814711
Jan 201944219
Feb 201923116
Mar 201925734
Apr 201924916
May 201932626
Jun 201922122
Jul 201921924
Aug 201932412
Sep 201931618
Oct 201901818
Nov 20193137
Dec 201971414
Jan 2020368
Feb 202022017
Mar 202022317
Apr 202041617
May 202032612
Jun 202022312
Jul 2020177
Aug 2020274
Sep 202052417
Oct 202012113
Nov 202021010
Dec 202021318
Jan 20218622
Back to top
Download PDF
Citation Tools
Print

Alerts
Email

KEYWORDS

Cost-Benefit Analysis
Diagnostic Tests, Routine
Encephalitis, Herpes Simplex
Herpes Simplex
polymerase chain reaction
Simplexvirus
cost-effectiveness
herpes simplex virus
polymerase chain reaction

Related Articles

Cited By...